tirzepatide compound news today Compounding pharmacies can resume making as FDA reconsiders shortage Zepbound copycats remain online despite
Description
Patients should verify that: Their assigned provider is licensed in their state of residence The provider has conducted an appropriate medical evaluation before prescribing The compounding pharmacy is licensed and operates under state pharmacy board oversight The telehealth platform complies with HIPAA privacy requirements Compounding Pharmacy Standards The company states that medications are prepared by compounding pharmacies operating under state pharmacy regulators and applicable compounding standards

doi: 10.2337/dc20-2151 53 FDA News release

Both the SURMOUNT and The SURPASS clinical trials examined the effects of Tirzepatide in thousands of patients, demonstrating its safety and clinically significant benefits (2, 4)

Starting at a low dose (2.5 mg weekly) and gradually titrating upward every 4 weeks helps minimize gastrointestinal side effects

The SURPASS-2 trial, which directly compared tirzepatide to semaglutide 1 mg in type 2 diabetes, found comparable overall gastrointestinal adverse event profiles

Tirzepatides success in achieving medical weight loss comes from its ability to suppress appetite and regulate blood sugar levels
